Skip to content

Effect of 0.5% vs 0.375% Ropivacaine on Autonomous Nervous System

Comparison of the Effect of Ropivacaine 0.5% vs 0.375% on the Autonomous Nervous System During Shoulder Surgery in Beach Chair Position

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02125994
Enrollment
100
Registered
2014-04-29
Start date
2014-03-31
Completion date
2015-12-31
Last updated
2014-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Surgery, Interscalene Nerve Block, Ropivacaine

Brief summary

It is established that the local anesthetic that is administered during an interscalene block affects the autonomic outflow to the heart. This is very well seen during shoulder surgery when the patient is positioned in beach chair pasition. The investigators want to study the different effect of the two concentrations (0.5% and 0.375%) of ropivacaine on the autonomic nervous system through blood pressure and heart rate measurements.

Interventions

Sponsors

Larissa University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Elective shoulder surgery * Age 18- 80 years old * ASA I - IV * Beach chair position

Exclusion criteria

* Coagulopathy disorders * Infection at the puncture site for the interscalene block * Neurological deficit on the side to be operated * Allergy to local anesthetics * Psychiatric disorders * Patient's refusal * Problems with patient communication * Failure of the interscalene block

Design outcomes

Primary

MeasureTime frame
Blood pressure fluctuationsCompletion of the surgery

Secondary

MeasureTime frame
Heart rate fluctuationsCompletion of surgery

Countries

Greece

Contacts

Primary ContactMarina Simaioforidou, Medicine
msimaiof@otenet.gr0000306972202573

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026